Insider · CIK 0001932525
Davis Andrew
Reports to the SEC for 1 company · BOSTON, MA
Transactions
14
Companies
1
Filings
9
CIK
0001932525
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2024-11-18 | IRWDIRONWOOD PHARMACEUTICALS INCS Sale | −$21.9K |
| 2024-05-20 | IRWDIRONWOOD PHARMACEUTICALS INCS Sale | −$147K |
| 2024-03-08 | IRWDIRONWOOD PHARMACEUTICALS INCM Exercise/Conversion | — |
| 2024-03-08 | IRWDIRONWOOD PHARMACEUTICALS INC · Performance-based Restricted Stock UnitM Exercise/Conversion | — |
| 2024-02-12 | IRWDIRONWOOD PHARMACEUTICALS INCS Sale | −$150K |
| 2024-02-12 | IRWDIRONWOOD PHARMACEUTICALS INCA Award | — |
| 2024-02-12 | IRWDIRONWOOD PHARMACEUTICALS INC · Performance-based Restricted Stock UnitA Award | — |
| 2023-11-20 | IRWDIRONWOOD PHARMACEUTICALS INCS Sale | −$31.9K |
| 2023-05-22 | IRWDIRONWOOD PHARMACEUTICALS INCS Sale | −$63.8K |
| 2023-03-08 | IRWDIRONWOOD PHARMACEUTICALS INCA Award | — |
| 2023-03-08 | IRWDIRONWOOD PHARMACEUTICALS INC · Performance-based Restricted Stock UnitsA Award | — |
| 2023-02-28 | IRWDIRONWOOD PHARMACEUTICALS INCS Sale | −$20.6K |
| 2023-02-27 | IRWDIRONWOOD PHARMACEUTICALS INCS Sale | −$20K |
| 2022-11-21 | IRWDIRONWOOD PHARMACEUTICALS INCS Sale | −$38.6K |
Recent filings
- 4Davis Andrew0000950170-24-129228SEC(opens sec.gov)
- 4Davis Andrew0000950170-24-063482SEC(opens sec.gov)
- 4Davis Andrew0000950170-24-029910SEC(opens sec.gov)
- 4Davis Andrew0000950170-24-015548SEC(opens sec.gov)
- 4Davis Andrew0001209191-23-056446SEC(opens sec.gov)
- 4Davis Andrew0001209191-23-031873SEC(opens sec.gov)
- 4Davis Andrew0001209191-23-017873SEC(opens sec.gov)
- 4Davis Andrew0001209191-23-014276SEC(opens sec.gov)
- 4Davis Andrew0001209191-22-058607SEC(opens sec.gov)
Companies
Address
C/O IRONWOOD PHARMACEUTICALS, INC. 100 SUMMER STREET, SUITE 2300
BOSTON, MA, 02110